Register entry

Biogen MA Inc.

Data as of · How to read this entry

Registered sites
0
Active NDC listings
6
Labeller names
2
Live patents
3
Exclusivities
1
Countries
0
Catalogue

Drug listings by form and route

6

6 active NDC listings: 6 human prescription drug. By marketing category: BLA 3, NDA 3.

Dosage formNDCs
capsule3
injection3
RouteNDCs
intravenous3
oral3
Labeller name on the listingNDCs
biogen ma inc3
biogen ma inc.3
Exclusivity

Patents and exclusivities

3
PatentProductCoversExpiry
10385341QALSODYtofersensubstance, productApr 2035
10669546QALSODYtofersenuseApr 2035
10968453QALSODYtofersenuseApr 2035
ProductExclusivityUntil
QALSODYTOFERSENODE-432 Orphan drugApr 2030
Catalogue

Marketed products

6
BrandGeneric nameForm / routeNDC
TofidenceTocilizumabinjection, intravenous64406-022BLA
TofidenceTocilizumabinjection, intravenous64406-023BLA
TofidenceTocilizumabinjection, intravenous64406-024BLA
ZURZUVAEzuranolonecapsule, oral64406-029NDA
ZURZUVAEzuranolonecapsule, oral64406-030NDA
ZURZUVAEzuranolonecapsule, oral64406-031NDA
Compare

Other companies listing tocilizumab

Enquiry

Common questions

Is Biogen MA Inc. FDA approved?
Biogen MA Inc. holds no registered establishment of its own; 6 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
What drugs does Biogen MA Inc. make?
6 products are listed under Biogen MA Inc. in the openFDA NDC Directory, most often as capsule; injection. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.